EMBC — Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Company profile

• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic
• Country: US
• Exchange: NASDAQ
• Employees: 2,000
• Website: https://www.embecta.com

Latest SEC filings for EMBC

• SCHEDULE 13G/A — 2026-08-14
• 10-Q — 2026-08-07
• 8-K — 2026-08-07
• S-8 — 2026-08-07
• 8-K/A — 2026-07-31
• SCHEDULE 13G/A — 2026-05-27
• SD — 2026-05-22
• 8-K — 2026-05-15
• SCHEDULE 13G — 2026-05-05
• 8-K — 2026-05-05

Latest EMBC news

• 2026-10-01 — Reviewing Rockwell Medical (NASDAQ:RMTI) & Embecta (NASDAQ:EMBC)

Abrir análisis completo

Educational tool only — not investment advice.